152 related articles for article (PubMed ID: 2747625)
61. Quantitation of the criticality of chiral centers toward stereoselective recognition: epimeric eudismic analysis of 1,3-oxathiolane muscarinic agonists and antagonists.
Lehmann PA
Chirality; 1990; 2(4):211-8. PubMed ID: 2083143
[TBL] [Abstract][Full Text] [Related]
62. Structure-activity relationship for substance P inhibition of carbamylcholine-stimulated 22Na+ flux in neuronal (PC12) and non-neuronal (BC3H1) cell lines.
Simasko SM; Soares JR; Weiland GA
J Pharmacol Exp Ther; 1985 Dec; 235(3):601-5. PubMed ID: 2416906
[TBL] [Abstract][Full Text] [Related]
63. Analogues of carbacholine: synthesis and relationship between structure and affinity for muscarinic and nicotinic acetylcholine receptors.
Søkilde B; Mikkelsen I; Stensbøl TB; Andersen B; Ebdrup S; Krogsgaard-Larsen P; Falch E
Arch Pharm (Weinheim); 1996 Feb; 329(2):95-104. PubMed ID: 8851473
[TBL] [Abstract][Full Text] [Related]
64. Binding of [3H]perhydrohistrionicotoxin and [3H]phencyclidine to the nicotinic receptor-ion channel complex of Torpedo electroplax. Inhibition by histrionicotoxins and derivatives.
Aronstam RS; King CT; Albuquerque EX; Daly JW; Feigl DM
Biochem Pharmacol; 1985 Sep; 34(17):3037-47. PubMed ID: 2412560
[TBL] [Abstract][Full Text] [Related]
65. Cholinergic agents: effect of methyl substitution in a series of arecoline derivatives on binding to muscarinic acetylcholine receptors.
Moos WH; Bergmeier SC; Coughenour LL; Davis RE; Hershenson FM; Kester JA; McKee JS; Marriott JG; Schwarz RD; Tecle H
J Pharm Sci; 1992 Oct; 81(10):1015-9. PubMed ID: 1432612
[TBL] [Abstract][Full Text] [Related]
66. Conformational aspects of the muscarinic receptor interactions of bicyclic isoxazole ester bioisosteres of arecoline.
Lagersted A; Falch E; Ebert B; Krogsgaard-Larsen P
Drug Des Discov; 1993; 9(3-4):237-50. PubMed ID: 8400005
[TBL] [Abstract][Full Text] [Related]
67. Characterization of the presynaptic muscarinic receptor in synaptosomes of Torpedo electric organ by means of kinetic and equilibrium binding studies.
Kloog Y; Michaelson DM; Sokolovsky M
Brain Res; 1980 Jul; 194(1):97-115. PubMed ID: 7378848
[TBL] [Abstract][Full Text] [Related]
68. Isoarecolone-induced enhancement of delayed matching to sample performance in monkeys: role of nicotinic receptors.
Buccafusco JJ; Jackson WJ; Gattu M; Terry AV
Neuroreport; 1995 May; 6(8):1223-7. PubMed ID: 7662913
[TBL] [Abstract][Full Text] [Related]
69. Interactions of piperidine derivatives with the nicotinic cholinergic receptor complex from Torpedo electric organ.
Aronstam RS; Edwards MW; Daly JW; Albuquerque EX
Neurochem Res; 1988 Feb; 13(2):171-6. PubMed ID: 2452357
[TBL] [Abstract][Full Text] [Related]
70. Synthesis, pharmacology, and molecular modeling studies of semirigid, nicotinic agonists.
Waters JA; Spivak CE; Hermsmeier M; Yadav JS; Liang RF; Gund TM
J Med Chem; 1988 Mar; 31(3):545-54. PubMed ID: 3258034
[TBL] [Abstract][Full Text] [Related]
71. Effects of isoarecolone, a nicotinic receptor agonist in rodent models of nicotine dependence.
Shoaib M
Psychopharmacology (Berl); 2006 Oct; 188(2):252-7. PubMed ID: 16932923
[TBL] [Abstract][Full Text] [Related]
72. The actions of some esters of 4-hydroxyquinuclidine on guinea-pig ileum, atria and rat fundus strip.
Barlow RB; Kitchen R
Br J Pharmacol; 1982 Nov; 77(3):549-57. PubMed ID: 7139202
[TBL] [Abstract][Full Text] [Related]
73. Nicotinic receptor inhibition by Tetraponera ant alkaloids.
Kem WR; Wildeboer K; LeFrancois S; Raja M; Marszalec W; Braekman JC
Cell Mol Neurobiol; 2004 Aug; 24(4):535-51. PubMed ID: 15233377
[TBL] [Abstract][Full Text] [Related]
74. In vivo characterisation of novel efficacious muscarinic receptor agonists.
Freedman SB; Harley EA; Marwood RS; Patel S
Eur J Pharmacol; 1990 Oct; 187(2):193-9. PubMed ID: 2272360
[TBL] [Abstract][Full Text] [Related]
75. The effects of a new cholinolytic--8018--and its optical isomers on the central muscarinic and nicotinic receptors.
Niu WZ; Zhao DL; Liu CG
Arch Int Pharmacodyn Ther; 1990; 304():64-74. PubMed ID: 2241419
[TBL] [Abstract][Full Text] [Related]
76. 5,8-disubstituted indolizidines: a new class of noncompetitive blockers for nicotinic receptor-channels.
Daly JW; Nishizawa Y; Padgett WL; Tokuyama T; Smith AL; Holmes AB; Kibayashi C; Aronstam RS
Neurochem Res; 1991 Nov; 16(11):1213-8. PubMed ID: 1815137
[TBL] [Abstract][Full Text] [Related]
77. Cholinergic actions of false neurotransmitters: acetyldiethylcholine.
Aronstam RS; Buccafusco JJ
Neurosci Lett; 1982 Jan; 28(1):51-6. PubMed ID: 6278372
[TBL] [Abstract][Full Text] [Related]
78. The effect of suspension on nicotinic acetylcholine receptor number and affinity at the rat neuromuscular junction.
Royland JE; Weber LJ
Physiologist; 1989 Feb; 32(1 Suppl):S19-20. PubMed ID: 2727095
[No Abstract] [Full Text] [Related]
79. Synthesis and biological activity of 1,2,4-oxadiazole derivatives: highly potent and efficacious agonists for cortical muscarinic receptors.
Street LJ; Baker R; Book T; Kneen CO; MacLeod AM; Merchant KJ; Showell GA; Saunders J; Herbert RH; Freedman SB
J Med Chem; 1990 Oct; 33(10):2690-7. PubMed ID: 2213823
[TBL] [Abstract][Full Text] [Related]
80. Topological mapping and the ionic channel in an acetylcholine receptor.
Stroud RM
Soc Gen Physiol Ser; 1987; 41():67-75. PubMed ID: 2436314
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
